Shujiao He

1098 Xueyuan Ave
Shenzhen, 518060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness.

AML1-ETO hijacks a distal enhancer of NAT10 to reprogram glutathione metabolism and sustain leukemia stem cell stemness.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 01, 2026

Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model.

Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model.

Journal: Journal of translational internal medicine

Published: February 23, 2026

Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.

Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.

Journal: Cancer research

Published: October 04, 2024

Liver protects neuron viability and electrocortical activity in post-cardiac arrest brain injury.

Liver protects neuron viability and electrocortical activity in post-cardiac arrest brain injury.

Journal: EMBO molecular medicine

Published: February 24, 2024

DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia.

DNA methylation landscape reveals GNAS as a decitabine-responsive marker in patients with acute myeloid leukemia.

Journal: Neoplasia (New York, N.Y.)

Published: July 27, 2023

DNA methylation landscape reveals LIN7A as a decitabine-responsive marker in patients with t(8;21) acute myeloid leukemia.

DNA methylation landscape reveals LIN7A as a decitabine-responsive marker in patients with t(8;21) acute myeloid leukemia.

Journal: Clinical epigenetics

Published: December 03, 2022

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma.

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: July 01, 2022

The FLT3 Y842D mutation may be highly sensitive to midostaurin: a case report.

The FLT3 Y842D mutation may be highly sensitive to midostaurin: a case report.

Journal: The Journal of international medical research

Published: May 13, 2022

Low concentration triphenyl phosphate fuels proliferation and migration of hepatocellular carcinoma cells.

Low concentration triphenyl phosphate fuels proliferation and migration of hepatocellular carcinoma cells.

Journal: Environmental toxicology

Published: March 29, 2022

Prediction of Graft Survival Post-liver Transplantation by L-GrAFT Risk Score Model, EASE Score, MEAF Scoring, and EAD.

Prediction of Graft Survival Post-liver Transplantation by L-GrAFT Risk Score Model, EASE Score, MEAF Scoring, and EAD.

Journal: Frontiers in surgery

Published: August 04, 2021

Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.

Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.

Journal: Frontiers in oncology

Published: March 26, 2021

Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis.

Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis.

Journal: Frontiers in immunology

Published: March 21, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026